It's all in the name: Does nomenclature for indolent prostate cancer impact management and anxiety?-Reference-Cited by-同舟云学术

It's all in the name: Does nomenclature for indolent prostate cancer impact management and anxiety?

Published:2021-06-03 Issue:18 Volume:127 Page:3354-3360
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Hudnall Matthew T.¹^ORCID,Desai Anuj S.¹,Tsai Kyle P.¹,Weiner Adam B.¹^ORCID,Vo Amanda X.¹,Ko Oliver S.¹^ORCID,Jan Stephen²,Schaeffer Edward M.¹,Kundu Shilajit D.¹

Affiliation:

1. Department of Urology Northwestern University Feinberg School of Medicine Chicago Illinois

2. University of Maryland School of Medicine Baltimore Maryland

Funder

Urology Care Foundation

National Cancer Institute

Prostate Cancer Foundation

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.33621

Reference23 articles.

1. Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates

2. Cancer statistics, 2020

3. Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

4. Clinically Localized Prostate Cancer: ASCO Clinical Practice Guideline Endorsement of an American Urological Association/American Society for Radiation Oncology/Society of Urologic Oncology Guideline

5. Gleason 6 Prostate Cancer: Translating Biology into Population Health

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preferred labels and language to discuss low-risk lesions that may be cancer precursors: A review;Patient Education and Counseling;2024-09

2. Impact of the diagnostic label for a low-risk prostate lesion: protocol for two online factorial randomised experiments;BMJ Open;2024-08

3. Patient Perceptions of Standardized Risk Language Used in ACR Prostate MRI PI-RADS Scores;Journal of the American College of Radiology;2024-06

4. The influence of the “cancer” label on perceptions and management decisions for low-grade prostate cancer;JNCI: Journal of the National Cancer Institute;2023-06-07

5. Low‐risk prostate lesions: An evidence review to inform discussion on losing the “cancer” label;The Prostate;2023-02-22